One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?
dc.contributor.author | Uytun, S | |
dc.contributor.author | Polat, SE | |
dc.contributor.author | Tabakçi, SÖ | |
dc.contributor.author | Cinel, G | |
dc.contributor.author | Emiralioglu, N | |
dc.contributor.author | Yalçin, E | |
dc.contributor.author | Kiper, N | |
dc.contributor.author | Sen, | |
dc.contributor.author | Altintas, DU | |
dc.contributor.author | Çokugras, H | |
dc.contributor.author | Kilinç, AA | |
dc.contributor.author | Yazan, H | |
dc.contributor.author | Çollak, A | |
dc.contributor.author | Uzuner, S | |
dc.contributor.author | Ünal, G | |
dc.contributor.author | Yilmaz, A | |
dc.contributor.author | Çelik, S | |
dc.contributor.author | Damadoglu, E | |
dc.contributor.author | Irmak, I | |
dc.contributor.author | Demir, E | |
dc.contributor.author | Öztürk, G | |
dc.contributor.author | Basaran, E | |
dc.contributor.author | Bingöl, A | |
dc.contributor.author | Sapan, N | |
dc.contributor.author | Aslan, AT | |
dc.contributor.author | Asfuroglu, P | |
dc.contributor.author | Harmanci, K | |
dc.contributor.author | Köse, M | |
dc.contributor.author | Hangül, M | |
dc.contributor.author | Özdemir, A | |
dc.contributor.author | Özcan, G | |
dc.contributor.author | Gayretli, ZG | |
dc.contributor.author | Keskin, Ö | |
dc.contributor.author | Yüksel, H | |
dc.contributor.author | Özdogan, S | |
dc.contributor.author | Topal, E | |
dc.contributor.author | Çaltepe, G | |
dc.contributor.author | Can, D | |
dc.contributor.author | Ekren, PK | |
dc.contributor.author | Kiliç, M | |
dc.contributor.author | Süleyman, A | |
dc.contributor.author | Eyüboglu, TS | |
dc.contributor.author | Pekcan, S | |
dc.contributor.author | Çobanoglu, N | |
dc.contributor.author | Çakir, E | |
dc.contributor.author | Özçelik, U | |
dc.contributor.author | Dogru, D | |
dc.date.accessioned | 2025-04-10T10:37:37Z | |
dc.date.available | 2025-04-10T10:37:37Z | |
dc.identifier.e-issn | 1399-3003 | |
dc.identifier.issn | 0903-1936 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14701/43133 | |
dc.language.iso | English | |
dc.title | One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses? | |
dc.type | Meeting Abstract |